http://politics.guardian.co.uk/green/story/0,9061,964003,00.html
Questions remain over growth drugs in
chicken
Use of additives
to hasten poultry growth is back on the rise, despite
NFU pledge to phase
them out
James
Meikle
Tuesday May 27,
2003
The
Guardian
Question: Are the chickens
injected with growth promoters?
Answer: No,
none of the chickens covered by the farm assurance scheme
is injected with
antibiotic growth promoters.
That is how
Assured Chicken Production, the industry's
standards-setting body, and the
"little red tractor" scheme that seeks to
assure consumers about food
production standards, dealt with the issues of
chicken growth
promoters.
The standards body, funded by
membership and inspection fees, is
committed to proving the industry "does
understand and respond to consumer
concerns" - for example, about the use of
antibiotic growth promoters.
How strange
then that by yesterday, after the Guardian had talked to
members of the
industry, that question and answer had disappeared from the
body's website
which lists common queries about the assured chicken
scheme.
The problem is that the additives,
properly known as antibiotic
digestive enhancers, are not injected. They are
given in feed.
Peter King, of the National
Farmers' Union, a strong backer of the
tractor logo, suggests the answer
quoted above was directed at consumer
fears over additives such as hormones.
The NFU is committed to phasing out
growth promoters "over a sensible period
that does not lead to detrimental
animal welfare". The union says it is
"trying to promote quality
British
chicken".
Broiler chickens are
ready for the table at six to seven weeks old.
Use of low-dose drugs as
growth promoters became commonplace in British
agriculture quickly after
their introduction in the early 1950s. Experience
in the United States
suggested their use appeared to cancel out bacteria in
animals' intestines
which hindered the absorption of
nutrients.
But by the mid-1980s there was
mounting concern that their continual
use posed a threat to human health.
Sweden soon banned the drugs. In the
late 1990s, the Danish pig and poultry
industry stopped using them and the
European commission began action against
them. Seven of the drugs are
already banned and the use of the remaining four
will come to an end in
2006. Already, they cannot be used as veterinary drugs
to treat animal
disease.
One of the
growth promoters still in use in chicken production is
avilamycin. Commission
scientists were worried by the fact that an
antibiotic of the same class,
evernimicin, was in development for combating
"superbugs" in
hospitals.
In 2000, the Schering-Plough
drug company abandoned its product, which
it had named Ziracin after trials,
because "the balance between efficacy and
safety did not justify further
development of the product".
Last week,
the company said it was still not going ahead with
evernimicin but the Soil
Association believes that this family of drugs
could affect human medicine.
The association says there is still a
possibility that bacteria in people
could quickly develop resistance to such
drugs because food for humans might
stem from animals given
similar
antibiotics.
Marketing
edge
The manufacturer of avilamycin,
Eli Lilly, argues that there is no
safety issue and that the EC is banning
the drug from 2006 on philosophical
grounds - "it doesn't like the use of
growth promoters".
In the late 1990s, too,
the public revolted against the idea of food
being stuffed full of drugs, and
companies saw a marketing edge in saying
they would no longer use such
drugs.
Industry figures show that in 1998,
sales of the "active ingredient"
used in growth promoters amounted to 46
tonnes. The following two years saw
a fall to 23 tonnes and 24 tonnes,
respectively. Yet by 2001, the figure was
back up to 43 tonnes, and this was
before Assured Chicken Production had
allowed limited use once
more.
The difficulty explaining this rise
lies in a lack of detail from the
veterinary medicines directorate, the
government's watchdog body. It cannot
break down that figure of usage to
differentiate between that given poultry
and that given other
livestock.
Sales of other antibiotics, for
treating disease in Britain's farm
animals, rose by 10 tonnes to 459 tonnes
in the same period - since 2001 was
the year of the foot and mouth disease
outbreak. The veterinary medicines
directorate says the rise may be due
partly to more animals needing
treatment because of the EC ban on some growth
promoters in 1999.
But the Soil
Association says that voluntary measures by farm
producers to ensure more
prudent use of veterinary medicines generally, are
not
working.
The body is pressing Margaret
Beckett, the environment secretary, to
end the "drug culture" in farming. It
says it is not true to suggest, as Mrs
Beckett did in a letter to the
association recently, that the Danish poultry
industry faced a big increase
in the use of therapeutic drugs after its
voluntary ban on growth promoters.
"This increase in Denmark relates almost
entirely to pig production. The
overall use of antibiotics on Danish farms
has fallen
significantly."
Sir Colin Spedding, the
chairman of Assured Chicken Production, says
the organisation has had
representations from vets, producers and retailers,
pushing to reintroduce
growth promoters.
Although one in five
members used such drugs last year, they did not
use them in each flock or for
every production cycle. And among the 80% of
members who had not used the
drugs, application of therapeutic medicines had
risen
substantially.
Professor Spedding said
they had tried to avoid a public relations
problem, but had created a welfare
problem.
Growth promoters did prevent
disease and make chickens grow faster,
but campaigners against them
encouraged people "to think there is some
artificial stimulus to growth like
hormones".